Key notesNeonatal pain assessments are focused mostly on acute pain, whereas prolonged, persistent or chronic pain are relatively ignored; without clear definitions, these terms are often used interchangeably for newborns.An initial framework for defining neonatal pain terms is presented, derived from characteristics of the pain experienced, as well as behavioural and physiological response patterns of newborns.Explicit definitions of pain terms may facilitate future neonatal pain research and management.

 {#apa13936-sec-0004}

"*'Ideas need to be fruitful; they do not have to be right. And, curiously enough, the two do not necessarily go together.'* [1](#apa13936-bib-0001){ref-type="ref"} Peter W. Nathan, MD, FRCP (1914--2002)."

A scientific rationale for pain and its effects in human newborns were first presented thirty years ago [2](#apa13936-bib-0002){ref-type="ref"}. Multidisciplinary efforts have since fuelled significant progress in neonatal pain [3](#apa13936-bib-0003){ref-type="ref"}, exploring its underlying mechanisms [4](#apa13936-bib-0004){ref-type="ref"}, [5](#apa13936-bib-0005){ref-type="ref"}, describing its epidemiology in clinical settings [6](#apa13936-bib-0006){ref-type="ref"}, [7](#apa13936-bib-0007){ref-type="ref"}, defining its impact on the brain and subsequent development [8](#apa13936-bib-0008){ref-type="ref"}, [9](#apa13936-bib-0009){ref-type="ref"} or devising clinical assessment and management approaches [10](#apa13936-bib-0010){ref-type="ref"}, [11](#apa13936-bib-0011){ref-type="ref"}. Despite this progress, defining and identifying pain in newborns remains a major challenge. Descriptors such as acute, persistent, prolonged or chronic pain are often used interchangeably for newborns, without clear definitions for these terms. Explicit definitions may help reduce confusion and controversy among clinicians, improve assessment and management and inform study designs in neonatal pain research.

The International Association for the Study of Pain (IASP) defined pain as '*an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or **described** in terms of such damage'* (IASP Committee on Taxonomy, 1969, updated in 1994 and 2002)[12](#apa13936-bib-0012){ref-type="ref"}. This definition requires patients to **describe** their pain, by default establishing the primacy of self‐report as a 'gold standard'. Although widely accepted across all healthcare professions and biomedical disciplines, this definition lacks applicability to non‐verbal populations [13](#apa13936-bib-0013){ref-type="ref"}, [14](#apa13936-bib-0014){ref-type="ref"} and ignores the cognitive and social dimensions of pain [15](#apa13936-bib-0015){ref-type="ref"}. Indeed, pain in newborns was often discounted until the IASP Committee on Taxonomy added a note clarifying that, 'The inability to communicate verbally does not negate the possibility that an individual is experiencing pain' [16](#apa13936-bib-0016){ref-type="ref"}.

The question of conscious pain perception in the early preterm newborn (or foetus) has been hotly debated [17](#apa13936-bib-0017){ref-type="ref"}, [18](#apa13936-bib-0018){ref-type="ref"}, [19](#apa13936-bib-0019){ref-type="ref"}, [20](#apa13936-bib-0020){ref-type="ref"}, [21](#apa13936-bib-0021){ref-type="ref"}, [22](#apa13936-bib-0022){ref-type="ref"}, mainly because of its social, ethical and legal implications [23](#apa13936-bib-0023){ref-type="ref"}, [24](#apa13936-bib-0024){ref-type="ref"}, [25](#apa13936-bib-0025){ref-type="ref"}, [26](#apa13936-bib-0026){ref-type="ref"}. Consciousness was widely believed to reside in the cerebral cortex, thus putatively being absent or rudimentary in those without functional thalamocortical connections [20](#apa13936-bib-0020){ref-type="ref"}, [26](#apa13936-bib-0026){ref-type="ref"}, although mechanisms underlying the subcortical control of consciousness [27](#apa13936-bib-0027){ref-type="ref"}, [28](#apa13936-bib-0028){ref-type="ref"}, [29](#apa13936-bib-0029){ref-type="ref"} and functionality of the subplate zone [30](#apa13936-bib-0030){ref-type="ref"}, [31](#apa13936-bib-0031){ref-type="ref"}, [32](#apa13936-bib-0032){ref-type="ref"}, [33](#apa13936-bib-0033){ref-type="ref"} appear to challenge that default. Attempting to set forth criteria for early human consciousness would create the difficulties of 'measuring' consciousness and the conundrums of trying to prove or disprove whether consciousness is present at different stages of development [34](#apa13936-bib-0034){ref-type="ref"}, [35](#apa13936-bib-0035){ref-type="ref"}. For the purpose of this review, it is presumed that all viable newborns are capable of consciously perceiving and responding to pain [13](#apa13936-bib-0013){ref-type="ref"}, [14](#apa13936-bib-0014){ref-type="ref"}, [36](#apa13936-bib-0036){ref-type="ref"}, [37](#apa13936-bib-0037){ref-type="ref"}.

Given the absence of self‐report, pain assessment in newborns is challenging, particularly among ventilated preterm infants with a limited behavioural repertoire. Although numerous pain assessment methods have been devised, validated and implemented in clinical care [38](#apa13936-bib-0038){ref-type="ref"}, [39](#apa13936-bib-0039){ref-type="ref"}, most are focused on the acute, episodic pain resulting from clinically essential, frequently performed invasive procedures. Hartley et al. recently presented an EEG‐based measure of nociceptive brain activity evoked by acute noxious stimulation and reduced by a topical anaesthetic [40](#apa13936-bib-0040){ref-type="ref"}. This too applies only to acute pain, requires specialised expertise, equipment and analytic capabilities and has a relatively low sensitivity (57%, 64%) and specificity (65%, 68%) to be clinically useful [40](#apa13936-bib-0040){ref-type="ref"}.

The need to differentiate acute from prolonged pain was first proposed at the 8th World Congress on Pain [41](#apa13936-bib-0041){ref-type="ref"}, and an expert panel later recognised the ability of newborns to experience prolonged/chronic pain [42](#apa13936-bib-0042){ref-type="ref"}. To the clinician‐researcher, acutely painful events in newborns clearly appeared to cause pain‐related distress and could be standardised for research. Clinical examples of prolonged or persistent pain were harder to study---they defied quantification, occurred less frequently, and did not elicit reproducible responses in newborns [43](#apa13936-bib-0043){ref-type="ref"}, [44](#apa13936-bib-0044){ref-type="ref"}. Not surprisingly, therefore, only 10% of newborns in neonatal intensive care units (NICUs) received daily clinical assessments for prolonged, continuous pain [11](#apa13936-bib-0011){ref-type="ref"}.

Attempts to define chronic pain in the neonatal context have contributed greatly to our current understanding of pain in infancy [45](#apa13936-bib-0045){ref-type="ref"}, [46](#apa13936-bib-0046){ref-type="ref"}. A few methods to assess the *intensity* of prolonged/chronic pain were devised and validated (Table [1](#apa13936-tbl-0001){ref-type="table-wrap"}), but given the absence of clear definitions, other aspects specific for chronic pain (duration, periodicity, character or secondary effects) have not been addressed. Despite these gaps, clinicians are using therapies normally reserved for chronic pain in newborns without any clear indications [47](#apa13936-bib-0047){ref-type="ref"}, [48](#apa13936-bib-0048){ref-type="ref"}, [49](#apa13936-bib-0049){ref-type="ref"}, [50](#apa13936-bib-0050){ref-type="ref"}, or assessment of short‐term and long‐term risk/benefit ratios. Most clinicians can easily identify examples of *persistent pain* following tissue injury (circumcision, other post‐operative pain) or inflammation (necrotizing enterocolitis, pyelonephritis), as well as examples of *chronic pain* (osteogenesis imperfecta, epidermolysis bullosa), but a consensus for developing the taxonomy of pain terms specifically for newborn infants remains elusive [45](#apa13936-bib-0045){ref-type="ref"}, [46](#apa13936-bib-0046){ref-type="ref"}, [51](#apa13936-bib-0051){ref-type="ref"}.

###### 

Previous studies on persistent or chronic pain in newborns

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors, Year            Krechel & Bildner, 1995 [86](#apa13936-bib-0086){ref-type="ref"}          Debillon et al., 2001 [93](#apa13936-bib-0093){ref-type="ref"}                  Boyle et al., 2006 [43](#apa13936-bib-0043){ref-type="ref"}   Hummel et al., 2008 [87](#apa13936-bib-0087){ref-type="ref"}, [94](#apa13936-bib-0094){ref-type="ref"}   van Dijk et al., 2009 [95](#apa13936-bib-0095){ref-type="ref"}             Lundqvist et al., 2014 [96](#apa13936-bib-0096){ref-type="ref"}   van Ganzewinkel et al., 2014 [45](#apa13936-bib-0045){ref-type="ref"}
  ------------------------ ------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- ----------------------------------------------------------------- -----------------------------------------------------------------------
  Study design             Observational study                                                       Staff survey, observational study                                               Staff survey, within an ongoing RCT                           Observational study                                                                                      Observational study                                                        Observational studies, survey                                     Delphi survey, three rounds

  Number of subjects       24                                                                        76                                                                              22                                                            46                                                                                                       286                                                                        86                                                                294

  Number of observations   1382                                                                      76                                                                              89                                                            72                                                                                                       3600                                                                       246                                                               525

  Age group(s)             32--60 weeks PCA                                                          25--36 weeks GA                                                                 23--32 weeks GA                                               23--40 weeks GA                                                                                          24--42 weeks GA                                                            23--29 weeks GA                                                   N/A

  Male/Female              10/14                                                                     N/A                                                                             N/A                                                           21/25                                                                                                    174/112                                                                    N/A                                                               N/A

  Pain assessed            Post‐operative                                                            Preterm                                                                         Mechanical ventilation                                        Ventilated or post‐operative                                                                             Acute procedural                                                           Preterm and sick term                                             Post‐operative or mechanical ventilation

  Comparators              Objective Pain Scale                                                      None                                                                            NEOPAIN                                                       PIPP                                                                                                     Numeric Rating Scale                                                       None                                                              Likert scale

  Assessment method        CRIES Pain Scale                                                          EDIN scale                                                                      none                                                          N‐PASS                                                                                                   COMFORTneo scale                                                           ALPS‐Neo                                                          none

  Stimulus studied         Various surgical procedures (VPS placement to PDA closure)                Mechanical ventilation, NEC, surgical closure of PDA                            Mechanical ventilation                                        Mechanical ventilation, various surgical procedures                                                      Not defined                                                                Not defined                                                       Not defined (conditions associated with chronic pain)

  Parameters/Findings      Facial expression (grimace)                                               Facial activity                                                                 Facial expressions                                            Facial expression                                                                                        Facial tension                                                             Facial expression                                                 

                           Requires oxygen for SpO~2~ \< 95%                                         Body movements                                                                  Infant activity levels                                        Extremities, muscle tone                                                                                 Body movement                                                              Hand/foot activity                                                Increased energy consumption

                           Sleepless                                                                 Quality of sleep                                                                Posture/quality of movements                                  Behaviour state                                                                                          (body) Muscle tone                                                         Tone of extremities                                               Hyperalgesia/altered pain perception

                           Increased vital signs (BP and HR)                                         Response to nursing                                                             Response to handling                                          Changes in vital signs (HR, RR, BP, SpO~2~)                                                              Calmness/agitation                                                         Level of activity                                                 Hyperresponsive to all interactions or procedures

                           Crying                                                                    Consolability                                                                   Ventilator dyssynchrony                                       Crying/irritability                                                                                      Respiratory response/crying                                                Breathing pattern                                                 Recurrent or long‐lasting pain

                                                                                                                                                                                                                                                                                                                                                            alertness                                                                                                                                    no proximate event or procedure

  Validity                 Convergent: *R* ~s~ = 0.73, p \< 0.0001\                                  Discriminant: scores decreased 4.4 (0.4) pre‐ vs. post‐analgesia, p \< 0.0001   N/A                                                           Convergent: R~s~ = 0.83, p \< 0.0001\                                                                    Convergent: *r* = 0.83, p \< 0.0001;\                                      N/A                                                               N/A
                           Discriminant: scores decreased 3.0 pre‐ vs. post‐analgesia, p \< 0.0001                                                                                                                                                 Discriminant: scores decreased 3.05 pre‐ vs. post‐analgesia, p \< 0.0001                                 Discriminant: scores decreased 6.9 pre‐ vs. post‐analgesia, p \< 0.001;\                                                                     
                                                                                                                                                                                                                                                                                                                                                            Sensitivity 81% Specificity 90%                                                                                                              

  Reliability              Inter‐rater: R~s~=0.72, p \< 0.0001                                       Inter‐rater: weighted *κ* coefficients = 0.59--0.74 (0.69)                      N/A                                                           Inter‐rater: pain scale ICC 0.95‐0.97, p \< 0.001; sedation scale ICC 0.9--0.95, p \< 0.0001             Inter‐rater: weighted *κ* coefficients = 0.65--0.97 (0.79)                 Inter‐rater: ICC 0.91 (0.61--0.82 for items)                      N/A

  Internal consistency     N/A                                                                       Cronbach\'s *α* coefficient = 0.92                                              N/A                                                           Cronbach\'s *α* coefficient = 0.89                                                                       Cronbach\'s *α* coefficient = 0.88                                         Cronbach\'s *α* coefficient = 0.95                                N/A
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ALPS‐Neo = Astrid Lindgren\'s Children\'s Hospital Pain Scale; BP = Blood pressure; CRIES = Crying, Requires oxygen, Increased vital signs, Expression, Sleepless; EDIN = Échelle Douleur Inconfort Nouveau‐Né; GA = Gestational age; HR = Heart rate; ICC = Intraclass correlation coefficient; NEC = Necrotizing enterocolitis; N‐PASS = Neonatal Pain, Agitation and Sedation Scale; N/A = not available); PCA = Post‐conceptional age; PDA = Patent ductus arteriosus; *R* ~s~ = Spearman rank correlation coefficient; *r* = Pearson moment correlation coefficient; RCT = Randomised controlled trial; RR = Respiratory rate; SpO~2~ = Peripheral oxygen saturation.
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For adults, various professional societies define acute pain as that associated with tissue injury, whereas chronic pain is defined as pain that extends beyond the period of tissue healing, with levels of pathology insufficient to explain the presence and/or extent of pain. Pain signals may remain active for months or years, causing a 'persistent pain that disrupts sleep and normal living, ceases to have protective functions, and instead degrades health and functional capability'[12](#apa13936-bib-0012){ref-type="ref"}, [52](#apa13936-bib-0052){ref-type="ref"}, [53](#apa13936-bib-0053){ref-type="ref"}. Turk and Okifuji differentiated acute and chronic pain using criteria for duration and pathology, short‐lasting pain with high physical pathology reflects acute pain, whereas prolonged durations with low pathology represent chronic pain [54](#apa13936-bib-0054){ref-type="ref"}. However, most chronic pain conditions in adults represent an interplay between significant nociceptive inputs and psychosocial/cognitive factors [55](#apa13936-bib-0055){ref-type="ref"}. The 'expected healing period' for defining transitions from acute to chronic pain is variably pegged at one, three or six months [12](#apa13936-bib-0012){ref-type="ref"}, [52](#apa13936-bib-0052){ref-type="ref"}, [53](#apa13936-bib-0053){ref-type="ref"}, [54](#apa13936-bib-0054){ref-type="ref"}, [56](#apa13936-bib-0056){ref-type="ref"}.

Such time‐points clearly exclude newborn infants who have not lived long enough to experience chronic pain, whereas the examples for chronic pain commonly cited by clinicians (e.g. epidermolysis bullosa) usually portend some kind of ongoing tissue pathology [45](#apa13936-bib-0045){ref-type="ref"}, [46](#apa13936-bib-0046){ref-type="ref"}. Also, diseases associated with prolonged pain in newborns (e.g. necrotizing enterocolitis) may have variable and undefined durations of tissue pathology. An empirical approach may be justified therefore, for defining the pain terms commonly used in neonatal care. Putative definitions for acute, prolonged, persistent or chronic pain must be explicit and relevant to the transient newborn period; they must represent the types of pain being experienced, independent of their aetiology or management.

Limited evidence supports management of chronic or persistent pain in neonates, so why do definitions matter at all? We argue that defining an infant\'s pain would justify a bedside clinician\'s level of concern, focus their attention towards specific assessment methods and allow them to weigh the risks/benefits of appropriate interventions. Pain definitions will also stimulate further advances to: understand the epidemiology of neonatal pain, investigate the underlying mechanisms at different levels of neurologic maturity, identify biomarkers/patterns for psychophysical or molecular phenotyping, recognise genetic, epigenetic or other factors that place infants at high risk for poor outcomes or long‐term complications and lastly, develop targeted therapies for specific types of non‐acute pain [15](#apa13936-bib-0015){ref-type="ref"}, [54](#apa13936-bib-0054){ref-type="ref"}. Most clinical trials chose their subjects based on a few selected clinical characteristics, which may or may not match individual newborns with the therapies uniquely suited for their pain. Thus, inclusion criteria incorporating explicit pain definitions may improve homogeneity in clinical trials. As an initial starting point for defining the different pain terms used for newborns (Table [2](#apa13936-tbl-0002){ref-type="table-wrap"}), we should consider the following:

###### 

Suggested starting point for defining the pain terms used for neonatal pain

  Pain term                                           Onset                          Duration                                                      Character[a](#apa13936-note-0051){ref-type="fn"}   Primary hyperalgesia
  --------------------------------------------------- ------------------------------ ------------------------------------------------------------- -------------------------------------------------- -------------------------------------------
  Acute episodic                                      Immediate                      0--120[b](#apa13936-note-0052){ref-type="fn"} minutes         Sharp, well‐localised                              Present, mild, short‐lasting
  Acute recurrent                                     Immediate                      variable                                                      Sharp, well‐localised                              Present, moderate or severe
  Prolonged[c](#apa13936-note-0053){ref-type="fn"}    Rapid, may be gradual          One hour to 24[b](#apa13936-note-0052){ref-type="fn"} hours   Sharp, diffusely localised                         Present, moderate or severe
  Persistent[c](#apa13936-note-0053){ref-type="fn"}   Rapid or gradual, cumulative   one to seven days                                             Dull/sharp, diffusely localised                    Present, moderate or severe
  Chronic                                             Usually gradual                Eight days or longer                                          Dull, diffusely localised                          May be present or absent, mild if present

  Pain term                                           Secondary hyperalgesia        Allodynia                         Behavioural phenotype                                  Physiological phenotype
  --------------------------------------------------- ----------------------------- --------------------------------- ------------------------------------------------------ ----------------------------------------
  Acute episodic                                      Probably absent               Probably absent                   Strongly reactive and reflexive                        High peak, sympathetic activation
  Acute recurrent                                     Present, mild or moderate     Probably absent                   Weakly reactive or reflexive                           Prolonged peak, sympathetic activation
  Prolonged[c](#apa13936-note-0053){ref-type="fn"}    Mild or absent                Probably absent                   Strongly reactive on stimulation                       High plateau, sympathetic activation
  Persistent[c](#apa13936-note-0053){ref-type="fn"}   Present, mild or moderate     May be present, mild/moderate     Hyperreactive initially, later hyporeactive            Normal or low sympathetic activation
  Chronic                                             Present, moderate or severe   May be present, moderate/severe   Hyporeactive more often, could also be hyperreactive   Normal or suppressed sympathetic drive

Based on descriptions in adult patients, but may be discerned by a careful physical examination.

Some infants with increased sensitivity to pain may have a slower decay of the acute pain following an invasive procedure, thus justifying some overlap in the durations of acute episodic pain and prolonged pain.

Continuous pain may be characterised as either 'prolonged' or 'persistent'.

John Wiley & Sons, Ltd

Temporal features {#apa13936-sec-0005}
-----------------

Any painful experience is defined by its onset and duration, exemplifying the salient differences between acute and non‐acute pain. Acute pain occurs immediately with the onset of tissue injury or stimulation of an inflamed area, and it usually lasts for the duration of the stimulus or for brief periods thereafter (some infants experience a slower decay of pain compared to others). However, the durations assigned for acute, prolonged, persistent or chronic pain are arbitrary at best. In adults, some experts classify pain lasting longer than one month as chronic pain, whereas others consider pain as chronic only if it lasts for longer than three or six months [12](#apa13936-bib-0012){ref-type="ref"}, [52](#apa13936-bib-0052){ref-type="ref"}, [53](#apa13936-bib-0053){ref-type="ref"}, [54](#apa13936-bib-0054){ref-type="ref"}. Similarly, variable criteria are used for children [56](#apa13936-bib-0056){ref-type="ref"}, [57](#apa13936-bib-0057){ref-type="ref"}. Given the temporal characteristics of painful conditions in newborns, the length of the neonatal period, as well as time‐courses for developing long‐term effects of pain, tolerance to analgesic drugs or other systemic effects, we posit that pain lasting longer than seven days be considered as chronic pain in newborns. This should prompt further diagnostic efforts, re‐evaluation of current analgesic strategies, use of alternative therapies and longer‐term plans for preventing disability, promoting rehabilitation and restoring function.

Character of pain {#apa13936-sec-0006}
-----------------

For obvious reasons, precise descriptors cannot be chosen for the character of pain (e.g. burning, piercing and shooting) that newborns experience, but clinicians may attempt to discern how well it is localised, or whether it is associated with clear boundaries or not. In the developing nervous system, two features characterise neonatal pain processing: (i) the immature peripheral and central nervous systems are biologically primed towards lower thresholds for activation, excitation and transmission of nociceptive stimuli as compared to older ages; this feature is further accentuated in preterm infants [5](#apa13936-bib-0005){ref-type="ref"}, [51](#apa13936-bib-0051){ref-type="ref"}; (ii) dorsal horn neurons in the spinal cord have large, overlapping cutaneous receptive fields; stimulation of these receptive fields heightens nociceptive signalling and can evoke a long‐lasting excitability within the spinal cord [58](#apa13936-bib-0058){ref-type="ref"}, [59](#apa13936-bib-0059){ref-type="ref"}, [60](#apa13936-bib-0060){ref-type="ref"}. Indeed, inhibitory signalling in the spinal cord is weak or absent in newborns and develops gradually during infancy [61](#apa13936-bib-0061){ref-type="ref"}, [62](#apa13936-bib-0062){ref-type="ref"}. These features are likely to promote poorer localisation of pain in newborns, while also heightening its secondary effects.

Secondary effects {#apa13936-sec-0007}
-----------------

Tissue injury or inflammation leads to secondary effects such as hyperalgesia (increased pain to a stimulus that is normally painful) and allodynia (pain due to stimuli that do not normally provoke pain). Primary hyperalgesia localises to the area of tissue damage, whereas secondary hyperalgesia occurs in normal areas remote from the site of tissue damage. Despite their biological plausibility [5](#apa13936-bib-0005){ref-type="ref"}, [61](#apa13936-bib-0061){ref-type="ref"}, [63](#apa13936-bib-0063){ref-type="ref"}, [64](#apa13936-bib-0064){ref-type="ref"}, limited clinical evidence supports these phenomena in human newborns. Fitzgerald et al. reported primary hyperalgesia following heel lances in newborns and its reversal with topical anaesthetic cream [65](#apa13936-bib-0065){ref-type="ref"}, whereas Taddio et al. reported secondary hyperalgesia to venipuncture in one‐day‐old newborns of diabetic mothers, who had received multiple heel lances for monitoring blood glucose levels [66](#apa13936-bib-0066){ref-type="ref"}. Similarly, Andrews et al. reported signs of visceral and somatic hyperalgesia in infants undergoing abdominal surgery [67](#apa13936-bib-0067){ref-type="ref"}, [68](#apa13936-bib-0068){ref-type="ref"}. Allodynia has not been investigated in neonates with prolonged or persistent pain, although it may be more likely in infants with neurologic impairment [47](#apa13936-bib-0047){ref-type="ref"}, [48](#apa13936-bib-0048){ref-type="ref"}, [49](#apa13936-bib-0049){ref-type="ref"}, [50](#apa13936-bib-0050){ref-type="ref"} or in those experiencing opioid withdrawal [69](#apa13936-bib-0069){ref-type="ref"}, [70](#apa13936-bib-0070){ref-type="ref"}. A developmental allodynia appears to exist in preterm neonates [71](#apa13936-bib-0071){ref-type="ref"}, [72](#apa13936-bib-0072){ref-type="ref"}, [73](#apa13936-bib-0073){ref-type="ref"}, [74](#apa13936-bib-0074){ref-type="ref"}, [75](#apa13936-bib-0075){ref-type="ref"} (but not term neonates [76](#apa13936-bib-0076){ref-type="ref"}), manifesting as similar responses to non‐noxious and noxious stimuli. Standardised tests for allodynia need to be developed and performed in newborns with persistent or chronic pain.

Response patterns {#apa13936-sec-0008}
-----------------

The physiological and behavioural responses to acute pain are well characterised in newborns and used for pain assessments [38](#apa13936-bib-0038){ref-type="ref"}. Assessment methods developed from models of prolonged or chronic pain also show considerable overlap in the parameters chosen (Table [1](#apa13936-tbl-0001){ref-type="table-wrap"}), and some of these are different from acute pain [77](#apa13936-bib-0077){ref-type="ref"}. In older children, chronic pain is often associated with fatigue, insomnia, impaired cognition or executive function, physical disabilities and mood disturbances [56](#apa13936-bib-0056){ref-type="ref"}, [57](#apa13936-bib-0057){ref-type="ref"}, [78](#apa13936-bib-0078){ref-type="ref"}. These may be absent or difficult to assess in newborns, particularly among those receiving neonatal intensive care [45](#apa13936-bib-0045){ref-type="ref"}, [46](#apa13936-bib-0046){ref-type="ref"}, [51](#apa13936-bib-0051){ref-type="ref"}. Behavioural responses generally manifest as 'distress'[38](#apa13936-bib-0038){ref-type="ref"}, [79](#apa13936-bib-0079){ref-type="ref"}, varying in severity and incorporating facial expressions [80](#apa13936-bib-0080){ref-type="ref"}, gross body movements [81](#apa13936-bib-0081){ref-type="ref"}, [82](#apa13936-bib-0082){ref-type="ref"} and subtle movement of hands, fingers or toes [81](#apa13936-bib-0081){ref-type="ref"}, [83](#apa13936-bib-0083){ref-type="ref"}. Physiological responses are incorporated into most assessment scales for acute pain, measuring increased sympathetic activity [38](#apa13936-bib-0038){ref-type="ref"} (and lower parasympathetic tone? [84](#apa13936-bib-0084){ref-type="ref"}, [85](#apa13936-bib-0085){ref-type="ref"}). Although scales such as CRIES [86](#apa13936-bib-0086){ref-type="ref"} and N‐PASS [87](#apa13936-bib-0087){ref-type="ref"} do include changes in vital signs, it is arguable whether neonates facing acute procedural pain versus chronic pain will show similar changes in vital signs. An increased sympathetic drive may not occur in chronic or persistent pain. Heart rate variability, for example, increases during acute pain but is diminished in response to persistent or chronic pain [88](#apa13936-bib-0088){ref-type="ref"}, [89](#apa13936-bib-0089){ref-type="ref"}.

Could the spectrum of rehabilitative interventions used for adult chronic pain be analogous to the behavioural and environmental interventions advocated for newborn care? These include everything from relationship‐based models of nursing to management of temperature, light, sound, and circadian rhythms, kangaroo care, sensorial saturation and other interventions [90](#apa13936-bib-0090){ref-type="ref"}. As with adults in chronic pain, many drug‐based interventions may have unproven benefits and potential harms in newborns. Because of their greater potential for short‐term and long‐term adverse effects in infants [91](#apa13936-bib-0091){ref-type="ref"}, [92](#apa13936-bib-0092){ref-type="ref"}, we should consider the importance of investigating behavioural and environmental interventions for infant chronic pain as possibly safer than drug therapies [47](#apa13936-bib-0047){ref-type="ref"}, [48](#apa13936-bib-0048){ref-type="ref"}, [49](#apa13936-bib-0049){ref-type="ref"}, [50](#apa13936-bib-0050){ref-type="ref"}. Although future research will determine novel ways for assessing acute versus non‐acute pain in newborns, an empirical framework is proposed to help define various types of neonatal pain. Putative criteria may evolve from this framework, eventually leading to more accurate methods for studying the diverse types of pain experienced by human newborns.
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